Could Inflammation in Youth Pose a Future Risk? Why a Healed Gut Might Later Lean Towards Cancer

Although it was supposed to be healed, the cells hadn't returned to normal

Many people think "the inflammation is healed" once painful symptoms like abdominal pain, diarrhea, and bleeding subside. Indeed, the intestinal mucosa appears to recover, and daily life resumes. However, recent research has shown that healing is not necessarily a "complete reset." This study, introduced by foreign media, indicated that even after chronic intestinal inflammation disappears, traces of past damage remain in some intestinal cells, potentially creating a favorable environment for cancer development.

The focus this time was not on damage to the genes themselves, but on changes in the epigenome, which influence how easily those genes can be read. The research team tracked the intestines of mice with chronic colitis to see if changes remained in stem cells even after the inflammation subsided. They found that traces altering cell behavior persisted for over 100 days. Moreover, these traces were not transient but were passed on to the next generation of cells born from dividing stem cells. Inside tissues that appeared "healed" on the surface, only the cellular history quietly remained.

The key lies in the "memory of inflammation"

The study analyzed over 52,000 single cells, with a notable increase in the activity of a group of transcription factors called AP-1. AP-1 acts like a command center, directing how cells respond to stress or damage. Typically, it is involved in regeneration reactions to heal wounds, but if this switch becomes excessively easy to activate, it may lead to cancer-favorable responses when other abnormalities occur later. The research team perceives this state as a "memory of inflammation."

Importantly, this memory does not immediately lead to cancer itself. The traces of inflammation alone do not determine the onset of the disease. However, if mutations that promote cancerization are added later, the situation changes. In the study, when factors promoting tumor formation were given to tissues of mice that had recovered from inflammation, tumors grew faster and larger compared to tissues without a history of inflammation. It's as if the initial inflammation stacked "dry wood," and subsequent mutations became the "kindling." Even though the inflammation had ended, the cells were in a state prepared for the next blow.

Why this research is being taken seriously now

The significant interest in this discovery is due to the reality that colorectal cancer is increasing among younger generations. According to the American Cancer Society's 2026 statistics, the incidence rate for those under 50 increased by an average of 2.9% annually from 2013 to 2022. The international project PROSPECT, in which the research team participates, also identifies understanding the background of increasing colorectal cancer among younger people as a critical issue. Researchers believe that if this mechanism is confirmed in humans, chronic inflammation and environmental influences during youth could be linked to cancer risk years or even decades later.

Of course, it is premature to simplistically conclude that "the cause of early-onset colorectal cancer is inflammation." There are multiple candidates, such as diet, obesity, lack of exercise, gut microbiota, the impact of antibiotics, environmental factors, and screening status. What this study has shown is a much more specific molecular-level explanation of "how inflammation bridges to future carcinogenesis." The previously vague "between inflammation and cancer" now has a new line drawn by the persistent changes in the epigenome, which is significant.

On social media, the standout reactions were "surprise at the mechanism" and "expectations for application"

Looking at the reactions on social media based on public posts, there is a strong interest among researchers and medical professionals. On LinkedIn, a post by the lead author of the paper, Jason Buenrostro, received over 600 reactions and more than 10 comments, focusing on the point that "the same mutation can have different outcomes depending on the cell's history." In other medical and research-related posts, the understanding that "healed tissue is not necessarily back to normal" and "inflammation is not a temporary risk but an event that directs future diseases" is being shared.

On X, the paper spread mainly through official announcements from Nature and NIH, expanding as a topic within the research community. There are two main axes of reaction: one is the excitement over the discovery that "the mechanism by which inflammation makes cancer more likely has become visible," and the other is the expectation for application, such as "if we can target AP-1 and epigenome memory, it may lead to prevention and early intervention." On social media, the understanding that "inflammation is not a past event but writes future risks" was spreading.

On the other hand, there is no shortage of calm reactions

However, what also stands out in social media and commentary articles is the cautious view that "this is still mouse research." On related Reddit posts, it was clarified that epigenome memory alone does not cause cancer independently, and tumor growth accelerates due to subsequent mutations. Furthermore, it is not yet confirmed how long this memory lasts in humans, what degree of inflammation causes it, or whether it applies beyond ulcerative colitis and Crohn's disease. Research institutions also speak of future prospects with the condition "if verified in humans," indicating there is still a distance to clinical application.

This "cautious enthusiasm" is perhaps the most healthy response to this research. The mechanism is fascinating and explanatory. However, the message readers should take away is not "if you've experienced inflammation, you'll definitely get cancer." Rather, it's a realistic lesson that "even if the body seems healed, past events may remain at the cellular level," and therefore, "it's important not to prolong inflammation, to undergo necessary tests, and not to overlook abnormalities." As research progresses, a future may come where such "inflammation history" can be read from stool or tissue, allowing early identification of high-risk individuals.

How to deal with invisible scars

We usually tend to think of disease in terms of "presence or absence." If there is inflammation, it's a disease; if it subsides, it's health. However, this study has shown a world that cannot be captured by that dichotomy. Even if symptoms disappear, cells may remember the past. And that memory may change the future in unexpected ways when the next event occurs. Intestinal inflammation may not be an event that ended, but rather a "prehistory" that changes the body's options over a long period. That's why it's important not to take inflammation lightly and to listen to the body's signals even after healing. This accumulation becomes the first step in quietly distancing future risks.

Source URL

WELT
https://www.welt.de/gesundheit/article69c3c01bd9e61ae4ac08b5d0/krebs-wie-entzuendungen-den-darm-noch-jahre-spaeter-anfaelliger-machen-koennen.html

Original Paper (Nature paper showing the relationship between post-inflammatory epigenome memory and tumor growth)
https://www.nature.com/articles/s41586-026-10258-4

Research Institution Explanation 1 (NIH research summary: 52,000 cell analysis, over 100 days of persistence, AP-1 explanation)
https://www.nih.gov/news-events/news-releases/chronic-inflammation-leaves-long-lasting-impression-gut-stem-cells-increasing-colorectal-cancer-risk

Research Institution Explanation 2 (Broad Institute explanation: context of increasing colorectal cancer in younger people, direction for future human verification)
https://www.broadinstitute.org/news/how-inflammation-may-prime-gut-cancer

Research Project Background (PROSPECT and the challenge setting of early-onset colorectal cancer)
https://www.cancergrandchallenges.org/news/the-epigenome-remembers-and-primes-for-cancer-risk

Statistical Background (American Cancer Society data on the increase in colorectal cancer among younger people)
https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html

Supplementary Commentary Article (Reference for organizing the "two-step model" and future diagnostic applications)
https://www.progress.org.uk/epigenetic-changes-from-colitis-may-increase-colorectal-cancer-risk/

SNS Reaction Source 1 (LinkedIn post by lead author Jason Buenrostro: checking reaction numbers and comment trends)
https://www.linkedin.com/posts/jason-buenrostro-51514514_epigenetic-memory-of-colitis-promotes-tumour-activity-7442741514549608448-jZgY

SNS Reaction Source 2 (Medical and research-related LinkedIn post: checking the research community's reception)
https://www.linkedin.com/posts/arianna-sab%C3%B2_epigenetic-memory-of-colitis-promotes-tumour-activity-7445188541074190336-YnNm

SNS Reaction Source 3 (Related LinkedIn posts and comments: checking cautious views and reaction numbers)
https://www.linkedin.com/posts/johanvanhylckamavlieg_epigenetic-memory-of-colitis-promotes-tumour-activity-7443369439732862977-Pcnu

SNS Reaction Source 4 (Reddit summary post: checking visible cautious views in the public domain)
https://www.reddit.com/r/microbiomenews/comments/1sg1yp3/scientists_found_your_gut_remembers_past_illness/